Application
IHC-P analysis of human ovarian adenocarcinoma tissue using Atg5 antibody [EPR1755(2)] at a dilution of 1:100.Application
WB analysis of lysates from (1) Raji, (2) HeLa, (3) HT-1080, (4) human fetal kidney, (5) C6, (6) Raw264.7, (7) PC-12 and (8) NIH3T3 (10 μg per lane) using Atg5 antibody [EPR1755(2)] at a dilution of 1:1,000.| Product Name | ATG5 antibody |
|---|---|
| Antibody Type | Primary Antibodies |
| Product description | Rabbit monoclonal antibody [EPR1755(2)] to ATG5 |
| Immunogen | Synthetic peptide corresponding to residues in Human APG5L/ATG5. |
| Clonality | Monoclonal |
|---|---|
| Isotype | IgG |
| Clone Number | EPR1755(2) |
| Host Species | Rabbit |
| Tested Applications | ICC/IFIHC-PIPWB |
| ICC/IF:1:200~1:500 IHC-P:1:50~1:200 IP:1:100~1:500 WB:1:500~1:2000 Notes:Optimal dilutions/concentrations should be determined by the researcher. |
|
| Species Reactivity | HumanMouseRat |
| Concentration | 1mg/ml |
| Gene Synonyms | ASP HAPG5 APG5 ATG5 APG5-LIKE APG5L |
|---|---|
| Target | ATG5 |
Application
IHC-P analysis of human ovarian adenocarcinoma tissue using Atg5 antibody [EPR1755(2)] at a dilution of 1:100.
Application
WB analysis of lysates from (1) Raji, (2) HeLa, (3) HT-1080, (4) human fetal kidney, (5) C6, (6) Raw264.7, (7) PC-12 and (8) NIH3T3 (10 μg per lane) using Atg5 antibody [EPR1755(2)] at a dilution of 1:1,000.| Application Notes | ICC/IF:1:200~1:500 IHC-P:1:50~1:200 IP:1:100~1:500 WB:1:500~1:2000 Notes:Optimal dilutions/concentrations should be determined by the researcher. |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | Store at -20°C. Stable for 12 months at -20°C |
| Storage Buffer | pH: 7.4. Preservative: 0.01% Sodium azide. Constituents: 50% Glycerol, 0.05% BSA |
